Multi-omics analysis reveals early-onset colorectal cancer patients exhibit epigenetic aging that exceeds their chronological age by more than a decade, coupled with enrichment for chromosomal instability-driven tumors and metabolic pathway dysregulation. The research identifies a convergence of obesity, insulin resistance, gut microbiome disruption, and exposure to modern environmental factors including microplastics and antibiotics as key contributors to this alarming trend. This finding fundamentally challenges our understanding of cancer timing and cellular aging. The accelerated epigenetic aging suggests these young patients' cells are experiencing biological stress equivalent to someone 10-15 years older, potentially explaining why traditionally 'old-age' cancers are appearing in younger populations. The metabolic-inflammatory axis appears central, with ultra-processed diets, sedentary behavior, and early-life exposures creating a perfect storm for premature cellular dysfunction. However, the observational nature of much evidence limits causal interpretations, and the controversial role of HPV as a cofactor remains unresolved. This represents a paradigm shift requiring us to reconceptualize colorectal cancer as a disease of accelerated biological aging rather than simply chronological age, with profound implications for screening strategies and prevention in younger adults.